tirzepatide and semaglutide injections versus Weight Loss Solutions - Collective Aesthetics™ Tirzepatide Shows Superior Weight Loss

PlexusDx serves all 50 states with no insurance required, and injections are HSA/FSA eligible

Psychosomatics 60 , 574581 (2019)

The Oral route of administration segment is anticipated to be the fastest-growing category with a CAGR of 10.2% from 2026 to 2033, driven by growing patient preference for non-injectable therapies, improving treatment compliance, and ongoing advancements in oral peptide drug delivery technologies

However, clinical evaluation will be necessary to confirm these properties in humans

For example, using our preferred 2mL reconstitution (which yields 2,500mcg/mL), a 250mcg dose is a simple draw to the "10" mark on the syringe barrel